Digital breast tomosynthesis (DBT) serves as an innovative medical imaging technique that relies on x-rays for creating highly detailed three dimensional images of the breasts. This cutting edge technology surpasses traditional mammography as the primary screening tool for detecting early indications of breast cancer. During DBT caregivers compress each breast while capturing multiple low dose X ray scans from varying angles; then they utilize specialized software for arranging these scans into a set of three dimensional images known as tomograms. By examining each slice in these tomograms one by one radiologists acquire unparalleled visibility amid overlapping tissues within the breasts—allowing them greater precision in identifying any abnormalities hidden within this complex tissue. Research has demonstrated that DBT enhances the outcomes of breast cancer screening by increasing detection rates while simultaneously decreasing false positive results compared to traditional mammography alone. For women with dense breasts who require routine screening for early signs of breast cancer, DBT is generally used alongside mammography and demonstrates a high degree of safety and tolerability. However, similar to mammography DBT does expose the patient’s breasts to ionizing radiation. It has been widely acknowledged that the advantages of catching breast cancer in its early stages far surpass any possible negative outcomes linked to radiation exposure. In other words detecting this disease early on can lead to a higher chance of survival for patients, which is a top priority for medical professionals and society as a whole.

Market Dynamics

The rising incidence of breast cancer worldwide is the main factor driving the global market for digital breast tomosynthesis equipment. The market has grown even more due to improvements in image quality and lower radiation exposure for patients brought on by developments in digital breast tomosynthesis technology. The value of early breast cancer screening is becoming more and more recognized by women, which has helped the market expand. For instance, in March 2021, according to the WHO (World Health Organization), in 2020 there were 2.3 million women diagnosed with breast cancer and 685000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most prevalent cancer.

Key features of the study:

• This report provides an in-depth analysis of the global digital breast tomosynthesis equipment market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global digital breast tomosynthesis equipment market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Hologic, Inc., Internazionale Medico Scientifica-S.R.L, GE Healthcare, Siemens Healthineers, Fujifilm Corporation, Planmed OY, Trivitron Healthcare, Varex Imaging Corporation, and Analogic Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global digital breast tomosynthesis equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital breast tomosynthesis equipment market.

Detailed Segmentation:

• Global Digital Breast Tomosynthesis Equipment Market, By Product Type:
  • Equipment
  • Upgradation
• Global Digital Breast Tomosynthesis Equipment Market, By End User:
  • Hospitals
  • Diagnostic Centers
• Global Digital Breast Tomosynthesis Equipment Market, By Region:
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Hologic, Inc. 
  • Internazionale Medico Scientifica-S.R.L
  • GE Healthcare
  • Siemens Healthineers
  • Fujifilm Corporation
  • Planmed OY
  • Trivitron Healthcare
  • Varex Imaging Corporation
  • Analogic Corporation